BofA Says Brace for Recession Shock After Worst Rout in 52 Years

image

(Bloomberg) — A “recession shock” begins for markets following the worst first-half for the S&P 500 in more than 50 years, Bank of America Corp.’s Chief Investment Strategist Michael Hartnett says.

While expectations of aggressive rate hikes by the Federal Reserve are peaking, inflation expectations are not, and Bofa’s bull and bear indicator remains at “maximum bearish” for a third week in a row, Hartnett wrote in a note.

Both stocks and bonds were rocked by outflows this week as investors fear the global economy could contract amid runaway inflation and hawkish central banks. About $5.8 billion exited global stock funds in the week through June 29, although US equities saw small inflows of about $0.5 billion, BofA said, citing EPFR Global data. Bonds had redemptions of $17 billion, the data show.

Markets have been roiled this year as investors dumped risk assets on worries of a looming recession while inflation remains sticky even as central banks kick off aggressive rate hikes. Stocks and bonds around the world combined have fallen by the most on record, according to Bloomberg data going back to 1990, with more than $8 trillion wiped off the S&P 500 Index alone in its worst first-half performance in over half a century.

Other seemingly bullish strategists broadly expect stocks to at least partially recover in the second half, according to Bloomberg surveys. But the likes of Michael Wilson at Morgan Stanley have warned of more declines until the market finds a bottom. Goldman Sachs Group Inc. strategists said on Friday that the risk of a renewed selloff in equity markets is still high as investors are only pricing a mild recession.

The upcoming earnings season is also going to be crucial for investors to gauge the impact of high prices and weaker consumer sentiment on corporate profits.

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More